Acarix has appointed Helen Ljungdahl Round as head of the company’s newly established US subsidiary Acarix Inc. Round will assume her position in September 2021 and build the US organization. She will be a member of Acarix AB’s Executive Management Group.   Acarix is a leader in AI driven diagnostics for immediate rule-out of coronary artery disease. The US Food and Drug Administration (FDA) has granted Acarix De Novo clearance for its CADScor System, which is an easy-to-use, rapid and non-invas...